249 related articles for article (PubMed ID: 26667309)
1. Recent advances in vaccine delivery.
Cordeiro AS; Alonso MJ
Pharm Pat Anal; 2016; 5(1):49-73. PubMed ID: 26667309
[TBL] [Abstract][Full Text] [Related]
2. Controlled delivery of antigens and adjuvants in vaccine development.
Zhao Z; Leong KW
J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136
[TBL] [Abstract][Full Text] [Related]
3. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.
Chatzikleanthous D; O'Hagan DT; Adamo R
Mol Pharm; 2021 Aug; 18(8):2867-2888. PubMed ID: 34264684
[TBL] [Abstract][Full Text] [Related]
4. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
Mrsny RJ
J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
7. Nanovaccines : nanocarriers for antigen delivery.
Gonzalez-Aramundiz JV; Cordeiro AS; Csaba N; de la Fuente M; Alonso MJ
Biol Aujourdhui; 2012; 206(4):249-61. PubMed ID: 23419252
[TBL] [Abstract][Full Text] [Related]
8. Biphasic lipid vesicles as a subcutaneous delivery system for protein antigens and CpG oligonucleotides.
Alcón VL; Baca-Estrada ME; Potter A; Babiuk LA; Kumar P; Foldvari M
Curr Drug Deliv; 2006 Apr; 3(2):129-35. PubMed ID: 16610999
[TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
10. Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.
Wang S; Liu H; Zhang X; Qian F
Protein Cell; 2015 Jul; 6(7):480-503. PubMed ID: 25944045
[TBL] [Abstract][Full Text] [Related]
11. Immunity in response to particulate antigen-delivery systems.
Storni T; Kündig TM; Senti G; Johansen P
Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
[TBL] [Abstract][Full Text] [Related]
12. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in vaccine adjuvants.
Singh M; O'Hagan DT
Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
16. Liposomal vaccine delivery systems.
Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in peptide-based subunit nanovaccines.
Skwarczynski M; Toth I
Nanomedicine (Lond); 2014 Dec; 9(17):2657-69. PubMed ID: 25529569
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanostructure vaccines: applications and challenges.
Simón-Vázquez R; Peleteiro M; González-Fernández Á
Expert Opin Drug Deliv; 2020 Jul; 17(7):1007-1023. PubMed ID: 32476491
[TBL] [Abstract][Full Text] [Related]
20. Lipid and carbohydrate based adjuvant/carriers in immunology.
McGeary RP; Olive C; Toth I
J Pept Sci; 2003 Jul; 9(7):405-18. PubMed ID: 12916638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
